Impact of Human papillomavirus 9-valent vaccine on viral clearance after surgical treatment: A single-center retrospective observational study
Human papillomavirus 9-valent vaccine was associated with a significant reduction in the proportion of women with a positive HPV test. These findings support its potential role in tertiary prevention of HPV-related cervical disease, particularly in reducing HPV persistence after surgical treatment.
Authors
- Mario Ascione (ORCID: https://orcid.org/0000-0002-7845-1149)
- Luigi Della Corte (ORCID: https://orcid.org/0000-0002-0584-2181)
- M Granata (ORCID: https://orcid.org/0000-0003-1771-3747)
- Virginia Foreste (ORCID: https://orcid.org/0000-0002-1120-4610)
- Giada Lavitola
- Mario Palumbo (ORCID: https://orcid.org/0000-0002-0670-2666)
- Giuseppe Bifulco (ORCID: https://orcid.org/0000-0001-7772-8591)
- Claudia Di Filippo
- Oriana Imperatore
Institutions
- University of Naples Federico II (IT)
Publication Details
- Journal
- European Journal of Obstetrics & Gynecology and Reproductive Biology
- Published
- 2025-04-20
- DOI
- https://doi.org/10.1016/j.ejogrb.2025.113994
- Citations
- 9
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 12.19